Tri-Solfen, pain relief product for dehorning, castration, tail docking and other painful procedures has now been successfully patented in the U.S. This provides commercial protection for the product to be used for topical pain and wound healing in all species of farm animals and humans, and follows-on from successful patents granted in the EU, Australia & New Zealand.
The developers of Tri-Solfen, Animal Ethics Pty Ltd’s Managing Director, Allan Giffard, states that “the patenting of Tri-Solfen is timely in these key international farming markets, as animal welfare is now a key focus of governments, consumers, producers, processors and retail chains such as Walmart, Sodexo, Nestle, Saputo, Aramark and many others”. He also states that “increasing numbers of consumers need assurance that their food and fibre is produced humanely and without cruelty”.
Allan Giffard is visiting North America this week to meet with potential commercial partners, and regulators to fast-track the use of Tri-Solfen in piglets and calves.
Tri-Solfen is currently registered in Australia for pain and wound management in sheep, with pending registration for its use in beef, pigs, goats, alpacas and companion animals.
Tri-Solfen is a farmer applied pain relieving spray gel that gives 24 hour topical analgesia to any open wound, and is now used by over 60 % of the Australian merino sheep industry.
Media Contact: Stephanie Gadsden – Director, Sustainability and Corporate Development +61 0 418 364 318